Summary/Conclusion
IORT results in effective disease control with acceptable toxicity and should be considered for selected patients with recurrent or persistent cancers of the head and neck.
Read MoreView Clinical research and studies by
January 18, 2006
Krempien, R. et al., “Intraoperative Electron-Beam Therapy for Primary and Recurrent Retroperitoneal Soft-Tissue Sarcoma.” (2006)
Summary/Conclusion
In selected patients, IOERT results in excellent local control and survival, with acceptable morbidity….IOERT in combination with EBRT seems to be able to compensate for minimal residual disease.
Read MoreJanuary 1, 2006
Lemanski, C. et al.,“Intraoperative Radiotherapy Given As A Boost For Early Breast Cancer: Long-term Clinical And Cosmetic Results.” (2006)
Summary/Conclusion
Our results confirm that IORT given as a boost after breast-conserving surgery is a reliable alternative to conventional postoperative fractionated boost radiation.
Read MoreDecember 27, 2005
Reitsamer, R. et al., “The Salzburg concept of intraoperative radiotherapy for breast cancer: Results and considerations.” (2006)
Summary/Conclusion
Immediate IORT-boost and whole breast irradiation yields excellent local control at 5 years, and was associated with a statistically significant decreased rate of IBTR compared with a similar cohort of patients treated with whole breast irradiation and conventional electron boost.
Read MoreDecember 15, 2005
Tran, Q. et al., “Clinical Outcomes of Intraoperative Radiation Therapy for Extremity Sarcomas.” (2006)
Summary/Conclusion
For patients with soft tissue sarcomas of the extremities, IORT used as a boost to EBRT provides excellent local control, with limited toxicities.
Read More